← The Wire
TRDANasdaq
Entrada Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1689375
Entrada Therapeutics develops genetic medicines for inaccessible intracellular targets, focusing on neuromuscular and inherited retinal diseases
red 8-K · 90d
$251M
Market cap
$7.71
Last close
-0.4%
1D
+9.1%
5D
240K
Volume
Price · last 39 sessions-51.2%
May 4L $5.65 · H $16.03Jun 29
96
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 10, 20268-KReg FD DisclosureMay 19, 202610-Q10-QMay 7, 20268-KResults of Operations · Reg FD DisclosureMay 7, 2026DEFA14ADEFA14AApr 29, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KResults of Operations · Reg FD DisclosureJan 8, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteJun 11, 2025DEFA14ADEFA14AJun 3, 20258-KExecutive Change · Reg FD DisclosureJun 3, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KExit / Disposal CostsApr 29, 2025DEFA14ADEFA14AApr 25, 2025DEF 14AFORM DEF 14AApr 25, 20258-KReg FD Disclosure · Company UpdateMar 24, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 20258-KReg FD Disclosure · Company UpdateFeb 24, 20258-KReg FD Disclosure · Company UpdateFeb 3, 20258-KResults of Operations · Company UpdateJan 15, 202510-Q10-QNov 5, 20248-KResults of OperationsNov 5, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KMaterial Agreement · Company UpdateJun 24, 2024424B5424B5Jun 24, 20248-KReg FD Disclosure · Company UpdateJun 24, 20248-KBylaw Amendment · Shareholder VoteJun 13, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 202410-K10-KMar 13, 20248-KResults of OperationsMar 13, 20248-KExecutive ChangeJan 3, 20248-KExecutive ChangeDec 6, 20238-KReg FD Disclosure · Company UpdateNov 22, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KMaterial Agreement · Company UpdateNov 1, 20238-KMaterial AgreementSep 29, 2023424B5424B5Sep 29, 20238-KCompany UpdateSep 21, 20238-KExecutive ChangeAug 10, 202310-Q/A10-Q/AAug 8, 202310-K/AFORM 10-K/AAug 8, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KReg FD Disclosure · Company UpdateAug 1, 20238-KExecutive Change · Shareholder VoteJun 8, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEFA14ADEFA14AApr 25, 2023DEF 14ADEF 14AApr 25, 20238-KExecutive ChangeApr 4, 202310-K10-KMar 6, 20238-KResults of OperationsMar 6, 20238-KReg FD Disclosure · Company UpdateFeb 9, 20238-KCompany UpdateJan 9, 20238-KCompany UpdateDec 19, 20228-KMaterial Agreement · Equity IssuanceDec 8, 202210-Q10-QNov 7, 20228-KResults of OperationsNov 7, 202210-Q10-QAug 11, 20228-KCompany UpdateAug 11, 20228-KShareholder VoteJun 3, 202210-Q10-QMay 12, 20228-KResults of OperationsMay 12, 2022DEFA14ADEFA14AApr 19, 2022DEF 14ADEF 14AApr 19, 20228-KMaterial Agreement · New Debt / ObligationMar 22, 202210-K10-KMar 15, 2022
Insider Activity
In the 90 days to Mar 10, 2026: 2 sold $508K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Dowden Nathan JPresident & COO | Sell | 11,894 | $13.05 | $155K |
| Mar 10, 2026 | Wentworth Kory JamesChief Financial Officer | Sell | 11,388 | $13.02 | $148K |
| Mar 9, 2026 | Wentworth Kory JamesChief Financial Officer | Sell | 5,089 | $13.00 | $66K |
| Mar 9, 2026 | Dowden Nathan JPresident & COO | Sell | 3,116 | $13.02 | $41K |
| Mar 4, 2026 | Wentworth Kory JamesChief Financial Officer | Sell | 7,988 | $12.25 | $98K |
| Nov 21, 2025 | Wentworth Kory JamesChief Financial Officer | Sell | 8,910 | $9.98 | $89K |
| Nov 20, 2025 | Baker FelixTenPercentOwner | Buy | 13,386 | $9.07 | $121K |
| Nov 20, 2025 | Baker FelixTenPercentOwner | Buy | 13,082 | $9.07 | $119K |
| Nov 20, 2025 | Baker FelixTenPercentOwner | Buy | 1,213 | $9.07 | $11K |
| Nov 20, 2025 | Baker FelixTenPercentOwner | Buy | 1,186 | $9.07 | $11K |
| Nov 14, 2025 | Parmar KushDirector,TenPercentOwner | Sell | 200,000 | $8.80 | $1.8M |
| Nov 14, 2025 | 5am Ventures V, L.P.TenPercentOwner | Sell | 200,000 | $8.80 | $1.8M |
| Nov 12, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 80,881 | $7.73 | $625K |
| Nov 12, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 11,494 | $7.95 | $91K |
| Nov 12, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 7,321 | $7.73 | $57K |
| Nov 12, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 1,040 | $7.95 | $8K |
| Nov 11, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 30,879 | $7.54 | $233K |
| Nov 11, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 11,701 | $7.39 | $86K |
| Nov 11, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 2,795 | $7.54 | $21K |
| Nov 11, 2025 | Baker Bros. Advisors (Gp) LlcTenPercentOwner | Buy | 1,059 | $7.39 | $8K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance